Literature DB >> 20634793

A prospective study of the accuracy and precision of continuous cardiac output monitoring devices as compared to intermittent thermodilution.

M Cecconi1, D Dawson, R Casaretti, R M Grounds, A Rhodes.   

Abstract

BACKGROUND: Pulse pressure (PP) analysis from a radial arterial line is available with the LiDCO plus monitor (LiDCO, Cambridge, UK) and FloTrac/Vigileo (Edwards Lifesciences, Irvine, CA, USA). The aim of this study was to investigate the agreement of continuous PP analysis against intermittent thermodilution (ITD) using the pulmonary artery catheter (PAC).
METHODS: This was a six-hour study in 29 patients monitored with a PAC. All measurements were referenced against CO measured from the average of four ITD curves from the PAC. The LiDCO plus was calibrated with a lithium dilution (PulseCOLi) and with ITD (PulseCOITD) at baseline. Measurements from Vigileo software 1.03 (APCO), LiDCO plus (PulseCOLi and PulseCOITD), CCO and ITD were taken every hour for the next six hours. The bias and precision between the two devices were calculated as well as the percentage error (PE) of agreement between the tested device and the reference. The coefficient of variation (CV) of the tested device was then derived.
RESULTS: The average bias, PE and coefficient of variation for CCO vs. ITD of the tested device were 0.3 L/min, 28% and 13%, respectively; for APCO vs. ITD the calculations were -1.1 L/min, 55% and 27%; for PulseCOLi Cardiac output Blood pressure Thermodilution. ITD they were 0.5 L/min, 40% and 19%; and for PulseCOITD vs. ITD they were 0.2 L/min, -31% and 15%.
CONCLUSION: APCO (Vigileo software 1.03) and PulseCOLi showed a moderate agreement with the PAC. When PulseCO was calibrated with ITD (PulseCOITD) it showed excellent agreement, demonstrating that PulseCO performs well against ITD when the calibration process is optimally performed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634793

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  6 in total

1.  A modified breathing pattern improves the performance of a continuous capnodynamic method for estimation of effective pulmonary blood flow.

Authors:  Caroline Hällsjö Sander; Thorir Sigmundsson; Magnus Hallbäck; Fernando Suarez Sipmann; Mats Wallin; Anders Oldner; Håkan Björne
Journal:  J Clin Monit Comput       Date:  2016-06-01       Impact factor: 2.502

2.  Non-invasive cardiac output and oxygen delivery measurement in an infant with critical anemia.

Authors:  Garry M Steil; Olive S Eckstein; Julie Caplow; Michael S D Agus; Brian K Walsh; Jackson Wong
Journal:  J Clin Monit Comput       Date:  2011-06-21       Impact factor: 2.502

3.  Pulse contour analysis of arterial waveform in a high fidelity human patient simulator.

Authors:  Paolo Persona; Elisabetta Saraceni; Francesca Facchin; Enrico Petranzan; Matteo Parotto; Fabio Baratto; Carlo Ori; Sandra Rossi
Journal:  J Clin Monit Comput       Date:  2017-10-03       Impact factor: 2.502

4.  Agreement between continuous and intermittent pulmonary artery thermodilution for cardiac output measurement in perioperative and intensive care medicine: a systematic review and meta-analysis.

Authors:  Karim Kouz; Frederic Michard; Alina Bergholz; Christina Vokuhl; Luisa Briesenick; Phillip Hoppe; Moritz Flick; Gerhard Schön; Bernd Saugel
Journal:  Crit Care       Date:  2021-03-29       Impact factor: 9.097

5.  Closed-loop assisted versus manual goal-directed fluid therapy during high-risk abdominal surgery: a case-control study with propensity matching.

Authors:  Joseph Rinehart; Marc Lilot; Christine Lee; Alexandre Joosten; Trish Huynh; Cecilia Canales; David Imagawa; Aram Demirjian; Maxime Cannesson
Journal:  Crit Care       Date:  2015-03-19       Impact factor: 9.097

Review 6.  Clinical review: Does it matter which hemodynamic monitoring system is used?

Authors:  Davinder Ramsingh; Brenton Alexander; Maxime Cannesson
Journal:  Crit Care       Date:  2013-03-05       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.